Motrin Ib Tablet, Film Coated
FDA Label NDC 53209-2001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Morning Star Otc for the product Motrin Ib (NDC 53209-2001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient (in each caplet), purposes, uses, allergy alert, stomach bleeding warning, heart attack and stroke warning, do not use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel-2 Tablets X 25 Pouches

Label (Motrin Ib 25 Pouches)

Label (Motrin Ib 25 Pouches)

* Please review the disclaimer below.